Riskpilot← Back to searchSign inGet full accessHOUZ AS
ASActiveOrg 911837080Bøveien 510, 8470 Bø I VesterålenButikkhandel med innredningsartikler ikke nevnt annet sted · NACE 47599Est. 20130 employees
Revenue 2023
NOK 2,6M
-25% vs 2022
EBITDA margin
-63.3%
-71% vs 2022
Equity ratio
-10829.2%
Financial strength
Net profit 2023
NOK -1,9M
-79% vs 2022
| Revenue | NOK 2,6M | -25% |
| EBITDA | NOK -1,7M | -71% |
| Net profit | NOK -1,9M | -79% |
| Total assets | NOK 25K | -99% |
| Equity | NOK -2,7M | -233% |
| Employees | 0 | — |
Legal name
HOUZ AS
Org number
911837080
Legal form
Aksjeselskap
NACE code
47599 · Butikkhandel med innredningsartikler ikke nevnt annet sted
Founded
19. april 2013
Share capital
NOK 180 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Bård arne brun
Company purpose
Selge interiørprodukter, møbler, klær, samt tilby interiørrådgivning.
Address
Bøveien 510, 8470 Bø I Vesterålen
Email
post@houz.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 684 | 2 526 | 3 301 | 3 868 | 4 346 | 3 916 | 3 354 | 4 702 | 4 624 | 3 471 | 2 610 |
| Staff expenses | −16 | −329 | −514 | −595 | −724 | −544 | −207 | −351 | −493 | −1 049 | −613 |
| EBITDA | 45 | 240 | 71 | 2 | −101 | 14 | −122 | 381 | 313 | −966 | −1 653 |
| Depreciation & amort. | −31 | −23 | −29 | −26 | −24 | −21 | −95 | −101 | −128 | −70 | −210 |
| EBIT | 14 | 218 | 42 | −24 | −125 | −7 | −217 | 280 | 185 | −1 036 | −1 863 |
| Net financials | −14 | −36 | −38 | −36 | −40 | −20 | −28 | −20 | −8 | −5 | −4 |
| Profit before tax | −0 | 182 | 5 | −60 | −165 | −27 | −245 | 260 | 177 | −1 041 | −1 867 |
| Tax | −0 | 49 | 1 | −15 | −0 | −0 | −0 | −0 | 17 | −0 | −0 |
| Net profit | −0 | 133 | 3 | −45 | −165 | −27 | −245 | 260 | 160 | −1 041 | −1 867 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 837 | 1 328 | 2 090 | 2 243 | 2 223 | 2 192 | 1 850 | 2 206 | 2 194 | 3 019 | 25 |
| Equity | 180 | 312 | 316 | 271 | 92 | 64 | −181 | 79 | 239 | −802 | −2 668 |
| Long-term debt | 600 | 800 | 1 580 | 1 785 | 1 950 | 2 000 | 2 000 | 1 800 | 1 700 | 2 904 | 2 690 |
| Short-term debt | 58 | 215 | 194 | 186 | 182 | 128 | 31 | 327 | 254 | 917 | 3 |
| Total debt | 658 | 1 015 | 1 774 | 1 971 | 2 132 | 2 128 | 2 031 | 2 127 | 1 954 | 3 821 | 2 693 |
EBITDA margin
-63.3%
This company
15.8%
Market median
-501% vs market
20132023
Equity ratio
-10829.2%
This company
38.2%
Market median
-28449% vs market
20132023
Return on equity
-186687400.0%
This company
18.4%
Market median
-1014605535% vs market
20132023
Net profit margin
-71.5%
This company
8.1%
Market median
-983% vs market
20132023
Asset turnover
105.94×
This company
1.12×
Market median
+9359% vs market
20132023
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20132023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-04-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LJ Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
RH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Chairman | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Global Pharma Group As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Global Pharma Group As
HOUZ AS Board members of HOUZ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Jannie Veggeland | Chief Executive Officer | 0 companies |
| Rita Holm Nilsen | Chief Executive Officer | 0 companies |
| Henrik Rødsand | Chairman | 0 companies |
| Henrik Hallstein Rødsand | Chairman | 0 companies |
| Thomas Kristoffer Storvestre | Chairman | 0 companies |
| Arne Veggeland | Chairman | 0 companies |